Longitudinal follow-up of individuals with opioid use disorder (LFU-OUD). 09/01/2021 - 08/31/2026. N01DA-19-2250. Task order 75N95021F00007 (TO26).
Ended Awarded Last action
- Contract number
- 75N95021F00007
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,822,096
Award facts
- Opportunity
-
- 75N95021F00007 Solicitation number
- Contract value 100% obligated
- $1,822,095.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$25,665 | |
| Original award | $1,847,761 |
About this award
The National Institute on Drug Abuse issued a delivery order to The Emmes Company, LLC on September 1, 2021, with a ceiling value of $1.82 million, under the NIDA Data, Statistics, and Clinical Trial Support Center IDV (N01DA-19-2250, Task Order 75N95021F00007) for longitudinal follow-up of individuals with opioid use disorder through August 31, 2026.
The parent IDV supports biostatistical analysis, data management, clinical trial coordination, regulatory support, and clinical research infrastructure services across NIDA's substance abuse treatment research portfolio. Place of performance is Rockville, MD. The order carries a cost-plus-fixed-fee pricing structure.
Actual government-invoiced labor under this delivery order totaled $1.36 million across FY2022–FY2025, spanning 6.1 FTEs and 10,740 contractor hours. The derived hourly rate declined year over year, averaging $198.21/hr in FY2022, $70.13/hr in FY2023, and $179.67/hr in FY2024. Most recent reported activity (FY2025) showed 1.0 FTE with no subcontractor engagement; Emmes self-performed all hours.
Quick answers
Who was awarded contract 75N95021F00007?
75N95021F00007 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 1, 2021.
How much is contract 75N95021F00007 worth?
The government has obligated $1,822,096 on 75N95021F00007.
Is contract 75N95021F00007 an order under another contract?
Yes. 75N95021F00007 is a delivery order under 75N95019D00013, an indefinite delivery contract.
Was contract 75N95021F00007 competed?
The extent of competition for 75N95021F00007 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award